Form D · Pharmaceuticals
Ethicann Pharmaceuticals Inc.
Toronto, A6 · CIK 0001767369
Offering snapshot reported May 3, 2022 · SEC filing
- Reported sold
- $25K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 3, 2022 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Oct 8, 2020 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Sep 4, 2020 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Sep 3, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 26, 2019 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jul 12, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 7, 2019 | Initial | $18,846 | No comparison | 1 | SEC filing |
| Feb 7, 2019 | Amendment | $18,846 | $0vs Feb 7, 2019 | 1 | SEC filing |
| Feb 7, 2019 | Amendment | $18,846 | $0vs Feb 7, 2019 | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-444163
Convertible Promissory Note and Warrant
Source: Form D, filed May 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Auritt | Director, Executive, Promoter |
| Ulrich Elben | Executive |
| Richard A Hoyt | Director |
| Dwayne Lashyn | Director |
| Bruce Mackler | Director, Executive, Promoter |
| Neil Marouka | Director |
| Neil Maruoka | Director |
| Brandon Price | Director, Executive, Promoter |
| James W Wishart | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
199 Bay Street Suite 5300 Commerce Court West
Toronto, A6, M5L 1B9
Toronto, A6, M5L 1B9